NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology
Helix Receives FDA Emergency Use Authorization for the HelixⓇ COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 Tests
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
Base Genomics announces company launch and raises $11 million USD to commercialize epigenetic technology for early and sensitive detection of cancer from liquid biopsy
QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients
BC Platforms Aims to Advance Clinical Decision-Making by Enhancing Clinical Data with Genomics Information